Perkins Coie Trust Co buys $2,589,138 stake in UnitedHealth Group Inc (UNH)

UnitedHealth Group Inc (UNH) : Perkins Coie Trust Co scooped up 235 additional shares in UnitedHealth Group Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 11, 2016. The investment management firm now holds a total of 18,751 shares of UnitedHealth Group Inc which is valued at $2,589,138.UnitedHealth Group Inc makes up approximately 1.65% of Perkins Coie Trust Co’s portfolio.

Other Hedge Funds, Including , Gofen Glossberg Il reduced its stake in UNH by selling 250 shares or 4.44% in the most recent quarter. The Hedge Fund company now holds 5,379 shares of UNH which is valued at $742,732. UnitedHealth Group Inc makes up approx 0.03% of Gofen Glossberg Il’s portfolio. Filament added UNH to its portfolio by purchasing 3,500 company shares during the most recent quarter which is valued at $478,310. UnitedHealth Group Inc makes up approx 0.22% of Filament’s portfolio. Franklin Street Advisors Inc Nc sold out all of its stake in UNH during the most recent quarter. The investment firm sold 1,475 shares of UNH which is valued $202,960.Bnp Paribas Arbitrage Sa boosted its stake in UNH in the latest quarter, The investment management firm added 313,125 additional shares and now holds a total of 459,451 shares of UnitedHealth Group Inc which is valued at $63,220,458. UnitedHealth Group Inc makes up approx 0.26% of Bnp Paribas Arbitrage Sa’s portfolio.

UnitedHealth Group Inc closed down -3.33 points or -2.41% at $134.75 with 33,53,588 shares getting traded on Tuesday. Post opening the session at $137.32, the shares hit an intraday low of $134.37 and an intraday high of $137.69 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, UnitedHealth Group Inc reported $1.96 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Jul 19, 2016. Analyst had a consensus of $1.89. The company had revenue of $46485.00 million for the quarter, compared to analysts expectations of $45039.08 million. The company’s revenue was up 28.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.64 EPS.

Many Wall Street Analysts have commented on UnitedHealth Group Inc. UnitedHealth Group Inc was Upgraded by Argus to ” Buy” on Jul 22, 2016. Company shares were Reiterated by RBC Capital Mkts on Jul 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 165 from a previous price target of $157 .Company shares were Reiterated by Mizuho on Jul 19, 2016 to “Buy”, Firm has raised the Price Target to $ 160 from a previous price target of $156 .

UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.

Leave a Reply

UnitedHealth Group Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on UnitedHealth Group Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.